Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Meeting report from the 10th International Congress of the Society for Melanoma Research, Philadelphia, PA, November 2013.

Vultur A, O'Connell M, Webster M, Villanueva J, Herlyn D, Somasundaram R, Krepler C, Zaidi R, Patton E, Sekulic A, Jonsson G, Weeraratna AT.

Pigment Cell Melanoma Res. 2014 Jul;27(4):E1-E12. doi: 10.1111/pcmr.12240. Epub 2014 May 6. No abstract available.

PMID:
24650043
[PubMed - in process]
2.

Bisphosphonamidate clodronate prodrug exhibits selective cytotoxic activity against melanoma cell lines.

Webster MR, Kamat C, Connis N, Zhao M, Weeraratna AT, Rudek MA, Hann CL, Freel Meyers CL.

Mol Cancer Ther. 2014 Feb;13(2):297-306. doi: 10.1158/1535-7163.MCT-13-0315. Epub 2013 Dec 5.

PMID:
24310621
[PubMed - in process]
3.

Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.

O'Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A, Li L, Herlyn M, Villanueva J, Liu Q, Yin X, Widura S, Nelson J, Ruiz N, Camilli TC, Indig FE, Flaherty KT, Wargo JA, Frederick DT, Cooper ZA, Nair S, Amaravadi RK, Schuchter LM, Karakousis GC, Xu W, Xu X, Weeraratna AT.

Cancer Discov. 2013 Dec;3(12):1378-93. doi: 10.1158/2159-8290.CD-13-0005. Epub 2013 Oct 8.

PMID:
24104062
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Change is in the air: the hypoxic induction of phenotype switching in melanoma.

O'Connell MP, Weeraratna AT.

J Invest Dermatol. 2013 Oct;133(10):2316-7. doi: 10.1038/jid.2013.208.

PMID:
24030649
[PubMed - indexed for MEDLINE]
5.

Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.

Caino MC, Chae YC, Vaira V, Ferrero S, Nosotti M, Martin NM, Weeraratna A, O'Connell M, Jernigan D, Fatatis A, Languino LR, Bosari S, Altieri DC.

J Clin Invest. 2013 Jul 1;123(7):2907-20. doi: 10.1172/JCI67841. Epub 2013 Jun 10.

PMID:
23921130
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A Wnt-er migration: the confusing role of β-catenin in melanoma metastasis.

Webster MR, Weeraratna AT.

Sci Signal. 2013 Mar 26;6(268):pe11. doi: 10.1126/scisignal.2004114. Review.

PMID:
23532332
[PubMed - indexed for MEDLINE]
7.

Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility.

Tavecchio M, Lisanti S, Lam A, Ghosh JC, Martin NM, O'Connell M, Weeraratna AT, Kossenkov AV, Showe LC, Altieri DC.

J Biol Chem. 2013 Feb 22;288(8):5553-61. doi: 10.1074/jbc.M112.433045. Epub 2013 Jan 9.

PMID:
23303179
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.

Sharma BK, Manglik V, O'Connell M, Weeraratna A, McCarron EC, Broussard JN, Divito KA, Simbulan-Rosenthal CM, Rosenthal DS, Zapas JL.

Int J Oncol. 2012 Nov;41(5):1570-6. doi: 10.3892/ijo.2012.1590. Epub 2012 Aug 17.

PMID:
22922842
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Molecular signature and in vivo behavior of bone marrow endosteal and subendosteal stromal cell populations and their relevance to hematopoiesis.

Balduino A, Mello-Coelho V, Wang Z, Taichman RS, Krebsbach PH, Weeraratna AT, Becker KG, de Mello W, Taub DD, Borojevic R.

Exp Cell Res. 2012 Nov 15;318(19):2427-37. doi: 10.1016/j.yexcr.2012.07.009. Epub 2012 Jul 27.

PMID:
22841688
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Automatic detection of melanoma progression by histological analysis of secondary sites.

Orlov NV, Weeraratna AT, Hewitt SM, Coletta CE, Delaney JD, Mark Eckley D, Shamir L, Goldberg IG.

Cytometry A. 2012 May;81(5):364-73. doi: 10.1002/cyto.a.22044. Epub 2012 Mar 29.

PMID:
22467531
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.

Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M, Wang GM, Jelovac D, Weeraratna A, Sherman Baust CA, Morin PJ, Toubaji A, Meeker A, De Marzo AM, Lewis G, Subhawong A, Argani P, Park BH.

Breast Cancer Res. 2012 Feb 9;14(1):R27.

PMID:
22321971
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

RAF around the edges--the paradox of BRAF inhibitors.

Weeraratna AT.

N Engl J Med. 2012 Jan 19;366(3):271-3. doi: 10.1056/NEJMe1111636. No abstract available.

PMID:
22256810
[PubMed - indexed for MEDLINE]
13.

A spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasis.

O'Connell MP, Weeraratna AT.

Pigment Cell Melanoma Res. 2011 Dec;24(6):1133-47. doi: 10.1111/j.1755-148X.2011.00918.x. Epub 2011 Nov 2. Review.

PMID:
21978367
[PubMed - indexed for MEDLINE]
14.

Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.

Eichhoff OM, Weeraratna A, Zipser MC, Denat L, Widmer DS, Xu M, Kriegl L, Kirchner T, Larue L, Dummer R, Hoek KS.

Pigment Cell Melanoma Res. 2011 Aug;24(4):631-42. doi: 10.1111/j.1755-148X.2011.00871.x. Epub 2011 Jun 9.

PMID:
21599871
[PubMed - indexed for MEDLINE]
15.

Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010.

Hersey P, Smalley KS, Weeraratna A, Bosenberg M, Zhang XD, Haass NK, Paton E, Mann G, Scolyer RA, Tüting T.

Pigment Cell Melanoma Res. 2011 Feb;24(1):e1-15. doi: 10.1111/j.1755-148X.2010.00811.x. Epub 2010 Dec 22. Erratum in: Pigment Cell Melanoma Res. 2011 Oct;24(5):989. Tüting, T [added].

PMID:
21232023
[PubMed - indexed for MEDLINE]
16.

Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.

Camilli TC, Xu M, O'Connell MP, Chien B, Frank BP, Subaran S, Indig FE, Morin PJ, Hewitt SM, Weeraratna AT.

Pigment Cell Melanoma Res. 2011 Feb;24(1):175-86. doi: 10.1111/j.1755-148X.2010.00792.x. Epub 2010 Dec 1.

PMID:
20955350
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report.

Eichhoff OM, Zipser MC, Xu M, Weeraratna AT, Mihic D, Dummer R, Hoek KS.

Melanoma Res. 2010 Aug;20(4):349-55. doi: 10.1097/CMR.0b013e32833bd89e.

PMID:
20526217
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Camilli TC, Weeraratna AT.

Biochem Pharmacol. 2010 Sep 1;80(5):702-11. doi: 10.1016/j.bcp.2010.03.002. Epub 2010 Mar 6. Review.

PMID:
20211149
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Lack of Wnt5A expression in Merkel cell carcinoma.

Weeraratna AT, Houben R, O'Connell MP, Becker JC.

Arch Dermatol. 2010 Jan;146(1):88-9. doi: 10.1001/archdermatol.2009.348. No abstract available.

PMID:
20083703
[PubMed - indexed for MEDLINE]
20.

Fat-storing multilocular cells expressing CCR5 increase in the thymus with advancing age: potential role for CCR5 ligands on the differentiation and migration of preadipocytes.

Mello Coelho Vd, Bunbury A, Rangel LB, Giri B, Weeraratna A, Morin PJ, Bernier M, Taub DD.

Int J Med Sci. 2009 Dec 4;7(1):1-14.

PMID:
20046229
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk